1. Screening Libraries
  2. Drug-Induced Liver Injury (DILI) Compound Library

肝脏毒性化合物库 - Drug-Induced Liver Injury (DILI) Compound Library

Cat. No.: HY-L076
Library Contents: XLSX PDF SDF

药物性肝损伤,也被称为药物诱导肝毒性(DILI),是由于药物(处方药及非处方药)、草药、食品添加剂及其他外源性物质导致的肝脏异常或功能障碍。药物是肝脏损伤的重要原因。药物性肝损伤是导致药物研发终止或撤市的最常见的原因。

DILI 已被证实是一个由多种机制参与的复杂病理过程,其中包括肝脏的结构和功能完整性的直接损害(例如线粒体功能障碍);产生改变肝细胞结构和功能的代谢产物;产生能与肝蛋白结合的反应性药物代谢产物,从而产生新的抗原性药物-蛋白质加合物,这些新的加合物被宿主的防御系统所针对(半抗原假说),并引发损害肝脏的全身超敏反应(即药物过敏)。

MCE 肝脏毒性化合物库包含 885 种肝脏毒性化合物,是进行肝损伤及相关药物毒理研究的有力工具,该化合物库也可以用来探究 DILI 发病机制,识别早期 DILI 标记物,在药物开发中及时发现并规避可能诱导肝损伤的药物设计,有助于药物的顺利上市。

我们将在明确您的产品用途后,向符合资质的客户通过定制合成服务的方式提供 MCE 肝脏毒性化合物库,我们为该库中的所有产品提供溶液包装或粉末包装。溶液包装中,869 个产品以 10 mM 浓度提供,14 个产品以 2 mM 浓度提供,2 个产品以 3 mg/mL 浓度提供。

溶液包装中,我们对于溶液状态稳定且溶解度不低于 10 mM 的产品,提供 10 mM 溶液;对于溶液状态稳定且溶解度介于 2~10 mM 的产品,我们提供 2 mM 溶液;对于溶液状态稳定、分子量不确定且溶解度不低于 3 mg/mL产品,我们提供 3 mg/mL 溶液。

  • 96-well Plate with Peelable Foil Seal
  • 384-well Microplate with Peelable Foil Seal
  • 96-well Storage Tubes with Rack
Size (Pre-dissolved Solution or Solid) Price Stock
30 μL/well Solution

10 mM , 2 mM and 3 mg/mL
Pre-dissolved Solution

Get quote In-stock
50 μL/well Solution

10 mM , 2 mM and 3 mg/mL
Pre-dissolved Solution

Get quote In-stock
100 μL/well Solution

10 mM , 2 mM and 3 mg/mL
Pre-dissolved Solution

Get quote In-stock
2 × 100 μL/well Solution

10 mM , 2 mM and 3 mg/mL
Pre-dissolved Solution

Get quote In-stock

Please contact us at

sales@MedChemExpress.cn

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Documentation

Description
& Advantages

•   A unique collection of 885 hepatotoxicity causing compounds for high throughput screening (HTS) and high content screening (HCS).

•   Including antibiotics, anti-cancer drugs, cardiac medications and anti-inflammatory agent, etc.

•   A useful tool for researching drug toxicity and mechanisms of DILI.

•   Including several different toxicities: steatosis, mitochondrial toxicity, cholestasis, drug allergy (hypersensitivity), etc.;

•   Structurally diverse, bioactive, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 885 drug-induced liver injury compounds supplied as pre-dissolved Solutions or Solid
Solution: 869 compounds supplied in 10 mM solution, 14 compounds supplied in 2 mM solution, 2 compounds supplied in 3 mg/mL solution.
Container:
96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Drug-Induced Liver Injury (DILI) Compound Library

Source: MedChem Express

Documentation

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

* Container:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Drug-Induced Liver Injury (DILI) Compound Library
    目录号:
    HY-L076
    需求量:

    Request SDF File

    Please enter your email address. We will send your requested SDF file to you as soon as possible.

    • 96-well Plate with Peelable Foil Seal
    • 384-well Microplate with Peelable Foil Seal
    • 96-well Storage Tubes with Rack
    • 96-well Storage Tubes with Rack